marchf5 Antibody

What is MARCHF5 and why is it significant in cellular research?

MARCHF5 (membrane associated ring-CH-type finger 5), also known as MARCH5, is a mitochondrial E3 ubiquitin ligase located in the outer mitochondrial membrane. This 278-amino acid protein has a molecular weight of approximately 31,232 daltons, though it can also exist as a homodimer of 65-70 kDa .

MARCHF5 is significant in cellular research because it:

• Regulates mitochondrial dynamics through ubiquitination of fusion/fission proteins

• Influences apoptosis by controlling BAK activation

• Participates in innate immunity via TLR7 signaling and NLRP3 inflammasome regulation

• Controls cellular senescence

• Protects against mitochondrial dysfunction

These diverse functions make MARCHF5 relevant to research in cancer, inflammatory disorders, aging, and neurodegenerative diseases.

What applications are MARCHF5 antibodies commonly used for in research?

MARCHF5 antibodies are utilized across multiple experimental techniques:

When selecting antibodies, researchers should verify reactivity (human, mouse, rat) and validate specificity through appropriate controls .

How should researchers design experiments to study MARCHF5-dependent ubiquitination of target proteins?

When studying MARCHF5-dependent ubiquitination:

• Experimental components:

  • Purified recombinant MARCHF5 or cellular expression systems

  • E1 and E2 ubiquitin-conjugating enzymes

  • Ubiquitin (unmodified or tagged)

  • ATP regeneration system

  • Suspected substrate proteins (e.g., NOXA, TANK, NLRP3)

• Control conditions:

  • RING domain mutant of MARCHF5 (H43W) as negative control

  • ATP-free reactions as negative control

  • Known substrates as positive controls

• Detection methods:

  • Western blotting with anti-ubiquitin antibodies

  • Mass spectrometry to identify ubiquitination sites

  • Fluorescence-based ubiquitination assays for kinetics

• Validation approaches:

  • Co-immunoprecipitation of MARCHF5 with targets

  • Knockout/knockdown of MARCHF5 to demonstrate dependency

  • Site-directed mutagenesis of substrate lysine residues

For example, researchers identified that MARCHF5 catalyzes K63-linked polyubiquitination of TANK on lysines 229, 233, 280, 302, and 306 , and K27-linked polyubiquitination of NLRP3 on K324 and K430 residues .

What controls are essential when using MARCHF5 antibodies for localization studies?

For rigorous MARCHF5 localization studies:

• Primary antibody specificity controls:

  • MARCHF5 knockout/knockdown cells

  • Peptide competition assays

  • Multiple antibodies targeting different epitopes

• Mitochondrial colocalization controls:

  • Co-staining with established mitochondrial markers (TOM20, MitoTracker)

  • Mitochondrial fractionation validation by Western blot

  • Comparison with MARCHF5 mutants that mislocalize from mitochondria

• Technical controls:

  • Secondary antibody-only controls

  • Isotype controls

  • Fixation method optimization (paraformaldehyde typically preferred)

• Functional validation:

  • Expression of MARCHF5-fluorescent protein fusions

  • Super-resolution microscopy to confirm outer membrane localization

  • Electron microscopy for highest resolution confirmation

Research has shown that MARCHF5's mitochondrial localization is critical for its function, as mislocalization abolishes its activity on targets like TANK, demonstrating the importance of confirming proper localization .

How can researchers distinguish between MARCHF5's direct and indirect effects on cellular processes?

Distinguishing direct from indirect effects requires:

• Enzymatic activity separation:

  • Use catalytically inactive MARCHF5 mutants (H43W)

  • Compare with substrate binding-deficient mutants

  • Perform in vitro ubiquitination assays with purified components

• Temporal resolution approaches:

  • Inducible expression/degradation systems

  • Time-course analyses after MARCHF5 manipulation

  • Pulse-chase experiments for protein turnover

• Domain-specific investigations:

  • Structure-function analyses with MARCHF5 deletion constructs

  • Point mutations in specific functional domains

  • Chimeric proteins swapping domains with related E3 ligases

• Substrate specificity validation:

  • Mutate potential ubiquitination sites on substrates

  • Perform direct binding assays

  • Employ proximity labeling techniques (BioID, APEX)

For example, studies differentiating MARCHF5's direct role in apoptosis regulation required demonstrating physical interaction with BAK and showing that this regulation depends on MARCHF5's E3 ligase activity, as opposed to indirect effects through mitochondrial morphology changes .

What considerations are important when interpreting contradictory data on MARCHF5 function across different cell types?

When reconciling contradictory data:

• Cellular context variations:

  • Expression levels of MARCHF5 and its substrates vary by cell type

  • Mitochondrial dynamics differ between proliferating, quiescent, and differentiated cells

  • Metabolic state influences MARCHF5 function

• Methodological differences:

  • Acute vs. chronic MARCHF5 depletion yields different phenotypes

  • Complete knockout vs. partial knockdown effects

  • Overexpression artifacts vs. physiological regulation

• Interaction network complexity:

  • Cell-type specific expression of MARCHF5 binding partners

  • Compensatory mechanisms through related E3 ligases

  • Phospholipid composition affects MARCHF5 activity

• Physiological triggers:

  • Stress-specific responses (inflammatory, metabolic, oxidative)

  • Cell cycle phase influences

For instance, MARCHF5 shows anti-apoptotic effects in cancer cells by regulating NOXA , while in other contexts it controls cellular senescence by modulating mitochondrial dynamics . These seemingly contradictory functions likely reflect different cellular contexts and experimental conditions.

How can MARCHF5 antibodies be optimized for studying protein-protein interactions in the mitochondrial membrane?

Optimizing MARCHF5 interaction studies:

• Membrane protein co-immunoprecipitation strategies:

  • Use mild detergents (digitonin, LMNG, DDM) to preserve membrane protein interactions

  • Employ chemical crosslinking before solubilization

  • Consider proximity labeling approaches (BioID, APEX)

  • Apply membrane fractionation before immunoprecipitation

• Native complex preservation:

  • Blue native PAGE for intact complexes

  • GraFix method for stabilizing complexes

  • On-bead digestion for mass spectrometry

• Spatial interaction detection:

  • Förster resonance energy transfer (FRET)

  • Proximity ligation assay (PLA)

  • Split fluorescent/luminescent protein complementation

• Antibody considerations:

  • Epitope accessibility in membrane-embedded regions

  • Recognition of post-translationally modified forms

  • Binding under native vs. denaturing conditions

Studies have successfully used these approaches to demonstrate MARCHF5 interactions with proteins like NOXA, showing that endogenous reciprocal co-immunoprecipitation experiments confirm MARCHF5 and NOXA are found in the same protein complex .

What methodologies can researchers use to investigate MARCHF5's role in the crosstalk between mitochondria and innate immunity?

To study MARCHF5 in mitochondria-immunity crosstalk:

• Cell-based inflammation models:

  • NLRP3 inflammasome activation assays (LPS + ATP/nigericin)

  • TLR7 signaling pathway activation (R837)

  • Bacterial infection models (C. rodentium, S. typhimurium, P. aeruginosa)

  • Viral infection systems activating RIG-I pathways

• Readouts for immune response:

  • Cytokine production (IL-1β, IL-18) by ELISA and Western blot

  • Caspase-1 activation assays

  • ASC speck formation by immunofluorescence

  • NF-κB reporter assays

• Genetic manipulation approaches:

  • Conditional knockout in specific immune cell populations

  • CRISPR/Cas9 genome editing of interaction domains

  • Myeloid-specific MARCHF5 conditional knockout mice

• Mechanistic dissection techniques:

  • Ubiquitination pattern analysis (K48 vs. K63 vs. K27-linked)

  • Mitochondrial recruitment of immune signaling components

  • Live-cell imaging of signaling complex formation

Research has demonstrated that MARCHF5 promotes K63-linked polyubiquitination of TANK in TLR7 signaling and K27-linked polyubiquitination of NLRP3 , revealing its role as a positive regulator of specific innate immune pathways.

What are the most common challenges when using MARCHF5 antibodies and how can they be addressed?

Common challenges and solutions include:

• Multiple band detection:

  • 31 kDa monomeric form and 65-70 kDa dimeric form may both appear

  • Use reducing agents to minimize dimerization

  • Include positive control lysates from cells expressing tagged MARCHF5

  • Consider antibodies targeting different epitopes to confirm specificity

• Low signal-to-noise ratio:

  • Optimize blocking conditions (5% BSA often preferred over milk)

  • Increase antibody concentration or incubation time

  • Use enhanced chemiluminescence substrates

  • Consider signal amplification methods for low-abundance detection

• Mitochondrial preparation artifacts:

  • Use gentle isolation methods to preserve outer membrane integrity

  • Include protease inhibitors and phosphatase inhibitors

  • Maintain samples at 4°C throughout processing

  • Verify mitochondrial fraction purity with markers

• Cross-reactivity issues:

  • Validate specificity with MARCHF5 knockout samples

  • Perform peptide competition assays

  • Use monoclonal antibodies for highest specificity

When interpreting results, be aware that MARCHF5 level and activity can be dramatically affected by cellular stresses and experimental conditions, as seen in studies showing how serum starvation affects MARCHF5 levels .

How should researchers design experiments to investigate the regulatory mechanisms controlling MARCHF5 activity?

To investigate MARCHF5 regulation:

• Post-translational modifications:

  • Phosphorylation studies using phosphatase inhibitors and Phos-tag gels

  • Analysis of autoubiquitination as activity measure

  • Mass spectrometry to identify modification sites

  • Site-directed mutagenesis of modified residues

• Lipid regulation:

  • Lipid binding assays with purified MARCHF5

  • Activity assays in the presence of different lipids

  • Altered lipid composition through genetic or pharmacological approaches

  • Measurement of ubiquitination activity with varying lipid ratios

• Protein-protein interaction regulation:

  • Mapping binding domains through truncation constructs

  • Effect of cellular stresses on interaction patterns

  • Competitive binding assays

  • Structural studies of regulatory complexes

• Subcellular localization dynamics:

  • Live-cell imaging of fluorescently tagged MARCHF5

  • Fractionation studies under different conditions

  • Effect of mitochondrial membrane potential on localization

  • Influence of mitochondrial fission/fusion state

Research has shown that phospholipids can significantly alter MARCHF5 activity and stability, with different lipid classes having distinct effects on its ubiquitination function . Additionally, cellular stressors like serum starvation can modulate MARCHF5 levels through lysosomal degradation pathways .